Vir Biotechnology Inc (NASDAQ: VIR) is -29.66% lower on its value in year-to-date trading and has touched a low of $4.32 and a high of $14.45 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The VIR stock was last observed hovering at around $5.93 in the last trading session, with the day’s loss setting it 0.0%.
Currently trading at $5.93, the stock is 12.01% and 13.46% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.06 million and changing 0.00% at the moment leaves the stock -18.85% off its SMA200. VIR registered -19.21% loss for a year compared to 6-month loss of -25.41%. The firm has a 50-day simple moving average (SMA 50) of $5.2265 and a 200-day simple moving average (SMA200) of $7.30745.
The stock witnessed a 9.21% gain in the last 1 month and extending the period to 3 months gives it a 14.26%, and is 9.21% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.26% over the week and 5.21% over the month.
Vir Biotechnology Inc (VIR) has around 408 employees, a market worth around $819.75M and $20.86M in sales. Profit margin for the company is -2769.04%. Distance from 52-week low is 37.27% and -58.96% from its 52-week high. The company has generated returns on investments over the last 12 months (-51.03%).
with sales reaching $2.38M over the same period.The EPS is expected to grow by 19.20% this year, but quarterly earnings will post -77.21% year-over-year. Quarterly sales are estimated to shrink -22.48% in year-over-year returns.
329.0 institutions hold shares in Vir Biotechnology Inc (VIR), with institutional investors hold 88.41% of the company’s shares. The shares outstanding are 138.06M, and float is at 89.11M with Short Float at 12.76%. Institutions hold 79.05% of the Float.
The top institutional shareholder in the company is SB INVESTMENT ADVISERS (UK) LTD with over 16.68 million shares valued at $148.49 million. The investor’s holdings represent 12.2466 of the VIR Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 16.43 million shares valued at $146.26 million to account for 12.0632 of the shares outstanding. The other top investors are VANGUARD GROUP INC which holds 12.85 million shares representing 9.4317 and valued at over $114.36 million, while STATE STREET CORP holds 3.7398 of the shares totaling 5.09 million with a market value of $45.34 million.
Vir Biotechnology Inc (VIR) Insider Activity
The most recent transaction is an insider sale by SATO VICKI L, the company’s Director. SEC filings show that SATO VICKI L sold 22,000 shares of the company’s common stock on Jul 01 ’25 at a price of $5.10 per share for a total of $0.11 million. Following the sale, the insider now owns 1.3 million shares.
